Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
75.5M
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
17.7M
-
Shares change
-
+11M
-
Total reported value, excl. options
-
$36.9M
-
Value change
-
+$23.2M
-
Number of buys
-
26
-
Number of sells
-
-8
-
Price
-
$2.08
Significant Holders of Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share (CLRB) as of Q4 2020
44 filings reported holding CLRB - Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share as of Q4 2020.
Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share (CLRB) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.7M shares
of 75.5M outstanding shares and own 23.42% of the company stock.
Largest 10 shareholders include Consonance Capital Management LP (4.07M shares), Sio Capital Management, LLC (2.33M shares), SILVERARC CAPITAL MANAGEMENT, LLC (1.77M shares), Maven Securities LTD (1.73M shares), VANGUARD GROUP INC (1.51M shares), 683 Capital Management, LLC (926K shares), BOXER CAPITAL, LLC (920K shares), Altium Capital Management LP (852K shares), BlackRock Inc. (710K shares), and Tri Locum Partners LP (658K shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.